Olaparib Impurity 42
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

763114-25-6Olaparib Impurity 42

● Auf Lager

Katalog-Nr.::VE0027727
CAS-Nr.::763114-25-6
Summenformel::C16H8FNO2
Molare Masse::265.24 g/mol

Online bestellen

Einheit Preis Menge Status Aktion
100 mg $129.00
● Auf Lager
Wir akzeptieren Credit Card Icons

Zusätzliche Informationen zu CAS 763114-25-6

Parent drug

Olaparib

IUPAC-Name

(Z)-2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile

Pharmacopeial Synonyms

N/A

Synonyme

N/A

SMILES

O=C(C1=C/2C=CC=C1)OC2=C/C3=CC=C(F)C(C#N)=C3

InChI

InChI=1S/C16H8FNO2/c17-14-6-5-10(7-11(14)9-18)8-15-12-3-1-2-4-13(12)16(19)20-15/h1-8H/b15-8-

Beschreibung

Olaparib Impurity 42 (CAS 763114-25-6) is a process-related and potential degradation impurity observed in olaparib manufacturing. Characterized by LC-MS and confirmed by NMR and HRMS, this polar impurity shows a distinct HPLC retention time and UV absorbance pattern complicating chromatographic resolution. Formation pathways include incomplete reaction, over-reduction or hydrolytic cleavage during workup or storage. Regulatory control is guided by ICH Q3A thresholds with identification and quantification by validated HPLC-UV and LC-MS/MS methods. Purification, tightening of reaction parameters, and stability stress testing are effective risk mitigation measures to limit levels and ensure drug substance quality and safety.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url